CSRXP APPLAUDS INCLUSION OF CREATES IN SPENDING DEAL; URGES CONGRESS TO KEEP WORKING TO HOLD BIG PHARMA ACCOUNTABLE, LOWER Rx PRICES
Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the… Read More

Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the… Read More
Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress… Read More
Revisions to Historic Trade Deal Remove Big Pharma Carveout Washington… Read More
Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times… Read More
Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers… Read More
Washington Can Put Patients First By Amending Trade Provision That Would… Read More
Trio of Committee Proceedings on Drug Pricing Offer Chance to Focus on Areas… Read More
Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of… Read More
Speaker’s Drug Pricing Plan Includes Measures That Have Won Support from… Read More
Inspector General Finds Negotiated Rebates Slowed Medicare Part D Price Hikes,… Read More
Orphan Drug Prices 25 Times More Expensive Than Traditional Drugs… Read More
Applauds HHS For Appealing Ruling Against List Price Transparency Measure… Read More